Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Terminated × pembrolizumab × Clear all

Phase

Phase 2 124 Phase 1 69 Phase 1/2 56 Phase 3 12 Phase EARLY_PHASE1 4 Phase NA 1 Phase 2/3 1

Status

Recruiting 5 Unknown 4 Completed 4 Active not recruiting 3 Terminated 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Radiosurgery 22 Magnetic Resonance Spectroscopy 19 Surveys and Questionnaires 18 Radiotherapy 17 Blood Specimen Collection 17 Exercise 15 Radiotherapy, Intensity-Modulated 14 Cyclophosphamide 12 Acupuncture Therapy 12 Methods 11 Cisplatin 11 Biopsy 11 Standard of Care 10 Interviews as Topic 10 Filgrastim 10 Early Intervention, Educational 10 Surgical Procedures, Operative 9 Radiofrequency Ablation 9 Magnetic Resonance Imaging 8 fludarabine phosphate 7 Sorafenib 7 Radiation 7 Granulocyte Colony-Stimulating Factor 7 Colonoscopy 7 Brachytherapy 7 X-Rays 6 Therapeutics 6 Gemcitabine 6 Fluorodeoxyglucose F18 6 Educational Status 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡